Boston Scientific (BSX) Tops Q2 EPS by 3c
Tweet
Share
E-mail
Get Alerts BSX Hot Sheet
Price: $45.60 +2.86%
EPS Growth %: +10.7%
Financial Fact:
Net income (loss): 228M
Today's EPS Names:
MAYS, CRMT, REPL, More
EPS Growth %: +10.7%
Financial Fact:
Net income (loss): 228M
Today's EPS Names:
MAYS, CRMT, REPL, More
Join SI Premium – FREE
Boston Scientific (NYSE: BSX) reported Q2 EPS of $0.40, $0.03 better than the analyst estimate of $0.37. Revenue for the quarter came in at $3.08 billion versus the consensus estimate of $2.94 billion.
GUIDANCE:
Boston Scientific sees FY2021 EPS of $1.58-$1.62, versus the consensus of $1.58.
For earnings history and earnings-related data on Boston Scientific (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- KB Home (KBH) Misses Q2 EPS by 2c; Offers Outlook
- Citrini flags overheating concerns as leverage, chip rally weigh on KOSPI
- Bernstein SocGen Group Reiterates Outperform Rating on Hermes International (RMS:FP) (HESAY) after cautious commentary
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
